Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.
Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.
JCAD’s coverage of the 2022 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).
JCAD
Journal of Clinical and Aesthetic Dermatology
©2026 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.